Director – US Lung Market Research
Revolution Medicines
Director – US Lung Market Research
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Executive Director, US Lung Analytics & Insights, the Director, US Lung Market Research will serve as the US Market Research lead for Revolution Medicines’ Lung cancer portfolio.
This role will partner closely with US Commercial, US Market Access, Global Insights, Medical Affairs, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance.
The role requires a strong understanding of the NSCLC cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.
This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.
Responsibilities include:
Leads, designs, and executes US primary market research projects with HCPs, patients, and payors
Initiates and facilitates activities that enhance partners’ knowledge regarding the relevant US market and potential product attitudes, usage, market dynamics, and competition (for example, development of treatment flows, target product profiles, opportunity assessments, and market landscape research).
Shares the voice of the US community (e.g., physicians, patients, payors) to the organization by maintaining and communicating a holistic understanding of the marketplace synthesized from primary and secondary sources.
Reinforces market research best practices, identify market research and data sources, vendor options, and methodologies that are best suited to address a business need. Manages third parties associated with this function.
Communicates and aligns key internal stakeholders around market research objectives and outputs including qualifying the results based on the strength of the data and identifying limitations.
Develops and presents timely final reports and actionable recommendations to key stakeholders, focusing on key findings and relevant implications to each stakeholder group, and senior leadership.
Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
Shapes situation analysis as a part of launch planning to provide a comprehensive understanding of the market. Partner with cross-functional teams like marketing, sales (when appropriate), access, and medical to provide a clear view of the market.
Demonstrates the ability to quickly understand complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics.
Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk.
Partner with US Forecasting, US Data Analytics, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
Required Skills, Experience and Education:
Bachelor's degree required (advanced degree preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a strategic analytics role.
Oncology market research experience required; NSCLC cancer experience strongly preferred.
Experience in market development and new product launches.
Extensive primary research and secondary analytical skills required; ability to translate the data and learning into actionable recommendations for business growth.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships
Demonstrated ability to influence senior management and key business partners.
Proven experience in a smaller, rapidly growing, company.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well with internal and external stakeholders, including strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
MBA, MPH, MS, or PhD.
Deep understanding of NSCLC and biomarker-driven oncology markets.
Experience supporting targeted oncology therapies.
Prior experience in a growth-stage biotechnology company.
#LI-JS1 #LI-Onsite
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 211000 - 264000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines